PHAXIAM Therapeutics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Thibaut Fayet
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | less than a year |
Board average tenure | 10.8yrs |
Recent management updates
Recent updates
ERYTECH receives non-compliance letter from Nasdaq
Oct 13Erytech Pharma reports 1H results
Sep 12Erytech drops plans to pursue FDA approval for leukemia therapy
Aug 24Our First Look At ERYTECH Pharma
Nov 16ERYTECH Pharma S.A. 2021 Q1 - Results - Earnings Call Presentation
May 06ERYTECH starts patient enrollment in pancreatic cancer study
Jan 14ERYTECH secures €10M in non-dilutive financing
Nov 02ERYTECH: Trials In Pancreatic Cancer
Oct 23CEO
Thibaut Fayet (55 yo)
less than a year
Tenure
Mr. Thibaut du Fayet serves as Chief Executive Officer at PHAXIAM Therapeutics S.A. since June 23, 2023. He served as Chief Operating Officer and served as Member of the Executive Board at Pherecydes Pharm...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Deputy CEO | 8.5yrs | €379.72k | 0.010% € 1.9k | |
Deputy CEO | 4.2yrs | €247.91k | 0.0063% € 1.2k | |
Chief Executive Officer | less than a year | no data | no data | |
Chief Technology Officer | less than a year | no data | no data | |
Chief Scientific Officer | 1.2yrs | no data | no data | |
Director Investor Relations | no data | no data | no data | |
Vice President of Human Resources | 8.1yrs | no data | 0.0014% € 268.6 | |
Chief Business Officer | less than a year | no data | 0.00066% € 124.8 | |
Chief Medical Officer | less than a year | no data | no data | |
Chief Regulatory Officer | less than a year | no data | no data | |
Consultant & Member of Scientific Board | no data | no data | no data | |
Consultant & Member of Scientific Board | no data | no data | no data |
0.8yrs
Average Tenure
52yo
Average Age
Experienced Management: PHXM's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Consultant & Member of Scientific Board | 14.2yrs | no data | no data | |
Consultant & Member of Scientific Board | 14.4yrs | no data | no data | |
Consultant & Member of Scientific Board | 12.2yrs | no data | no data | |
Consultant & Member of Scientific Board | 12.2yrs | no data | no data | |
Consultant & Member of Scientific Board | 12.2yrs | no data | no data | |
Independent Director | 10.8yrs | €66.00k | 0.017% € 3.2k | |
Vice Chairman | 10.8yrs | €572.43k | 0.0080% € 1.5k | |
Independent Director | 9.8yrs | €51.00k | 0.000020% € 3.8 | |
Independent Director | 9.5yrs | €51.00k | 0.000020% € 3.8 | |
Chairman of the Board | less than a year | no data | no data | |
Representative Director | 1.2yrs | no data | no data | |
Independent Director | less than a year | no data | no data |
10.8yrs
Average Tenure
62yo
Average Age
Experienced Board: PHXM's board of directors are seasoned and experienced ( 10.8 years average tenure).